Healthcare provider profile · identity verified

Kendria E. Holt-Rogers, M.D.

Internal Medicine · GRETNA, LA · NPI 1558572446

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	436	136
Rosuvastatin Calcium	Rosuvastatin Calcium	428	118
Amlodipine Besylate	Amlodipine Besylate	409	123
Losartan Potassium	Losartan Potassium	263	83
Metformin Hcl	Metformin Hcl	252	74
Gabapentin	Gabapentin	228	63
Omeprazole	Omeprazole	205	66
Hydrochlorothiazide	Hydrochlorothiazide	198	62
Furosemide	Furosemide	187	65
Lisinopril	Lisinopril	187	62
Metoprolol Succinate	Metoprolol Succinate	165	55
Pantoprazole Sodium	Pantoprazole Sodium	152	49
Carvedilol	Carvedilol	140	43
Levothyroxine Sodium	Levothyroxine Sodium	134	38
Fluticasone Propionate	Fluticasone Propionate	119	51
Hydralazine Hcl	Hydralazine Hcl	119	34
Alendronate Sodium	Alendronate Sodium	115	34
Metformin Hcl Er	Metformin Hcl	115	35
Albuterol Sulfate Hfa	Albuterol Sulfate	104	41
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	102	48
Tamsulosin Hcl	Tamsulosin Hcl	91	35
Eliquis	Apixaban	83	18
Glimepiride	Glimepiride	82	21
Glipizide	Glipizide	82	26
Trazodone Hcl	Trazodone Hcl	82	26
Ozempic	Semaglutide	80	19
Valsartan	Valsartan	80	28
Metoprolol Tartrate	Metoprolol Tartrate	76	23
Tramadol Hcl	Tramadol Hcl	76	44
Prednisone	Prednisone	75	32
Potassium Chloride	Potassium Chloride	70	24
Clopidogrel	Clopidogrel Bisulfate	68	21
Famotidine	Famotidine	68	29
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	65	15
Pravastatin Sodium	Pravastatin Sodium	65	19
Dropsafe Prep Pads	Alcohol Antiseptic Pads	63	19
Tizanidine Hcl	Tizanidine Hcl	63	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	61	18
Hydroxyzine Hcl	Hydroxyzine Hcl	59	20
Diclofenac Sodium	Diclofenac Sodium	57	28
Naproxen	Naproxen	57	22
Mirtazapine	Mirtazapine	53	22
Allopurinol	Allopurinol	52	17
Triamcinolone Acetonide	Triamcinolone Acetonide	48	27
Methocarbamol	Methocarbamol	47	19
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	45	39
Sertraline Hcl	Sertraline Hcl	43	15
Vitamin D2	Ergocalciferol (Vitamin D2)	42	21
Spironolactone	Spironolactone	41	12
Cephalexin	Cephalexin	40	37
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	40	13
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	39	17
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	37	suppressed
Montelukast Sodium	Montelukast Sodium	37	17
Ciprofloxacin Hcl	Ciprofloxacin Hcl	36	33
Oxybutynin Chloride Er	Oxybutynin Chloride	35	11
Methylprednisolone	Methylprednisolone	34	29
Citalopram Hbr	Citalopram Hydrobromide	32	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	32	suppressed
Duloxetine Hcl	Duloxetine Hcl	32	suppressed
Finasteride	Finasteride	32	suppressed
Nifedipine Er	Nifedipine	32	suppressed
Xarelto	Rivaroxaban	32	suppressed
Glipizide Er	Glipizide	31	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	30	suppressed
Trulicity	Dulaglutide	30	suppressed
Tradjenta	Linagliptin	28	suppressed
Buspirone Hcl	Buspirone Hcl	27	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	26	suppressed
Jardiance	Empagliflozin	26	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	24	17
Oxybutynin Chloride	Oxybutynin Chloride	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Ibuprofen	Ibuprofen	23	11
Bupropion Xl	Bupropion Hcl	22	suppressed
Ketoconazole	Ketoconazole	22	suppressed
Clobetasol Propionate	Clobetasol Propionate	21	suppressed
Linzess	Linaclotide	21	suppressed
Meloxicam	Meloxicam	21	11
Baclofen	Baclofen	20	suppressed
Azelastine Hcl	Azelastine Hcl	19	11
Farxiga	Dapagliflozin Propanediol	19	suppressed
Ondansetron Odt	Ondansetron	19	12
Irbesartan	Irbesartan	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	18
Fluconazole	Fluconazole	17	14
Ciclopirox	Ciclopirox	16	suppressed
Latanoprost	Latanoprost	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	14
Nitroglycerin	Nitroglycerin	16	11
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Torsemide	Torsemide	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Brilinta	Ticagrelor	15	suppressed
Meclizine Hcl	Meclizine Hcl	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Atenolol	Atenolol	14	suppressed
Azithromycin	Azithromycin	14	11
Entresto	Sacubitril/Valsartan	14	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	14	suppressed
Isosorbide Dinit-Hydralazine	Isosorbide Dinit/Hydralazine	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Simvastatin	Simvastatin	14	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	12	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	12	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	12	suppressed
Ezetimibe	Ezetimibe	12	suppressed
Risperidone	Risperidone	12	suppressed
Aimovig Autoinjector	Erenumab-Aooe	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	11	suppressed
Veltassa	Patiromer Calcium Sorbitex	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error